PrimeRFP SCOUT · Federal Contract Profile

Takeda Pharmaceuticals America (DDEVYUAXJ624)Federal contracts · 4 recompetes

Takeda Pharmaceuticals America holds $6.5M in federal volume across 96 award actions, with 62% at Department of Justice (DOJ). SCOUT tracks 4 incumbent recompetes — an estimated $1.2M returning to market over the next 24 months (Moderate exposure). Primary work: Pharmaceutical Preparation (100% prime). Obligations are down 10% year over year.

$6.5M
Federal Volume
4
Recompetes (24mo)
DOJ
Top Agency · 62% firm-wide
96
Award Actions

Choose one — this changes what we ask next

Score my firm against Takeda Pharmaceuticals America

Email me when a Takeda Pharmaceuticals America recompete window opens.

Data through · refreshed monthly · window Aug 2025 – Aug 2026

Why are you looking at Takeda Pharmaceuticals America?

Score my firm against Takeda Pharmaceuticals America

Email me when a Takeda Pharmaceuticals America recompete window opens.

What they do

Capability

Service lines

PHARMACEUTICAL PREPARATION MANUFACTURING

Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS

Recompete exposure: Moderate · 4 in 24mo

Takeda Pharmaceuticals America has an estimated $1.2M in contracts returning to market over the next 24 months.

Recompete exposure & trajectory

Recompete exposure

Moderate

Takeda Pharmaceuticals America has an estimated $1.2M in contracts returning to market over the next 24 months. 4 within 6 months ($1.2M).

Trajectory
Consolidating-10% YoYFY2025 vs FY2024
'23
'24
'25
SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…
Gwyne Taylor, Tailored Global
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Takeda Pharmaceuticals America hold?

Takeda Pharmaceuticals America (UEI DDEVYUAXJ624) shows $6.5M across 96 award actions in SCOUT’s public USASpending-backed profile, with Department of Justice (DOJ) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Takeda Pharmaceuticals America have?

Takeda Pharmaceuticals America shows $6.5M across 96 award actions. SCOUT tracks 4 incumbent recompetes ($1.2M) returning to market in the next 24 months.

Which agencies does Takeda Pharmaceuticals America work with?

Takeda Pharmaceuticals America’s firm-wide obligated mix is led by Department of Justice (DOJ) (62%), Department of Veterans Affairs (VA) (38%), Department of Defense (DOD) (0%).

What is the UEI for Takeda Pharmaceuticals America?

The Unique Entity ID (UEI) for Takeda Pharmaceuticals America is DDEVYUAXJ624.

Does Takeda Pharmaceuticals America have contracts coming up for recompete?

Yes — SCOUT tracks 4 incumbent recompetes in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Corpus refreshed Aug 20, 2026. Profile snapshot Aug 19, 2026.
primerfp.com/intel/company/takeda-pharmaceuticals-america-inc